NuEyne

BRINGING NEW LIGHT, NEW LIFE

View Product Now

BRINGING NEW LIGHT, NEW LIFE

Biomedical Engineering & Neuromodulation Technology based Electroceuticals R&D Company

Nu Eyne is a medical technology company that focuses on researching and developing the electroceuticals platform. Our current focus is to treat various neurological disorders, ranging from migraine and dry eye to tinnitus and various nerve injuries, by mimicking bioelectrical signals. We are adopting neuromodulation, tissue engineering and wearable devices for bringing a novel solution to various chronic diseases.

Media

NUEYNE’s NEWS

more view

Media

NUEYNE’s NEWS

more view
HISTORY

2019

October 17, 2019… MOU with Biomedical Engineering Research Center, Samsung Medical Center
October 8, 2019 … LOA B&VIIT Eye Center
September 19, 2019 … Company Presentation in LGC Life Sciences Forum
July 25, 2019 … MOU with Huons Co., Ltd.
July 19, 2019 … Approval of Medical Device GMP
June 14, 2019 … MOU with Biomedical Engineering Laboratory, Hanyang University
April 1, 2019 … Animal Study Results Presentation in ARVO 2019
March 15, 2019 … R&D Support Program from the Korean Ministry of Foods and Drugs Safety
January 21, 2019 … Manufacturing Facility in Seoul-si, Korea

2018

November 11, 2018 … Series A Investment (Approx. 3.5 million USD)
September 28, 2018 … Business Model Development with Johnson & Johnson
August 17, 2018 … Funding from the Korean Ministry of SMEs and Startups
June 26, 2018 … Company Presentation in Echelon Asia Summit, Singapore

2017

December 8, 2017 … Final Winner of Seoul Innovation QuickFire Challenge by J&J Innovation
October 31, 2017 … Seed Funding Investment

History

2019

October, MOU with Biomedical Engineering Research Center, Samsung Medical Center
October, LOA B&VIIT Eye Center
September, Company Presentation in LGC Life Sciences Forum
July, MOU with Huons Co., Ltd.
July, Approval of Medical Device GMP
June, MOU with Biomedical Engineering Laboratory, Hanyang University
April, Animal Study Results Presentation in ARVO 2019
March, R&D Support Program from the Korean Ministry of Foods and Drugs Safety
January, Manufacturing Facility in Seoul-si, Korea

2018

November, Series A Investment (Approx. 3.5 million USD)
September, Business Model Development with Johnson & Johnson
August, Funding from the Korean Ministry of SMEs and Startups
June, Company Presentation in Echelon Asia Summit, Singapore

2017

December, Final Winner of Seoul Innovation QuickFire Challenge by J&J Innovation
October, Seed Funding Investment